Agilent Technologies (A) Stock Analysis & Winston Score

Agilent Technologies makes scientific instruments and tools used in laboratories around the world. Its products include machines that measure chemicals, test food safety, analyze drugs, and study DNA. The main customers are pharmaceutical companies, biotech firms, hospitals, universities, and government labs. Agilent is one of the largest makers of laboratory instruments and chemical analysis equipment globally. Agilent makes money by selling hardware like mass spectrometers and liquid chromatography systems, along with software, consumables, and service contracts that generate recurring revenue. The company operates across the Americas, Europe, and Asia-Pacific, with a significant portion of sales coming from China, which is both a growth market and a risk. Its moat comes from the high switching costs of its instruments — once a lab is trained on Agilent equipment and workflows, changing to a competitor is expensive and disruptive. The key risk is that weakness in pharmaceutical and biotech spending, or continued pressure in the Chinese market, could weigh on revenue growth in the near term.